Commodore Capital LP Pharvaris N.V. Transaction History
Commodore Capital LP
- $1.02 Billion
- Q1 2025
A detailed history of Commodore Capital LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Commodore Capital LP holds 1,911,433 shares of PHVS stock, worth $34.4 Million. This represents 2.94% of its overall portfolio holdings.
Number of Shares
1,911,433
Previous 1,911,433
-0.0%
Holding current value
$34.4 Million
Previous $36.6 Million
18.1%
% of portfolio
2.94%
Previous 3.67%
Shares
4 transactions
Others Institutions Holding PHVS
# of Institutions
50Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$136 Million3.99% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$79.4 Million78.82% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$77.2 Million72.08% of portfolio
-
Viking Global Investors LP3.65MShares$65.8 Million0.19% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$59.5 Million17.41% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $608M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...